Variability in cyanobacteria sensitivity to antibiotics and implications for environmental risk assessment

Gareth Le Page; Lina Gunnarsson; Maciej Trznadel; Kyle C.A. Wedgwood; Virgile Baudrot; J. Snape; Charles R. Tyler

doi:10.1016/j.scitotenv.2019.133804

Variability in cyanobacteria sensitivity to antibiotics and implications for environmental risk assessment

Gareth Le Page, Lina Gunnarsson, Maciej Trznadel, Kyle C.A. Wedgwood, Virgile Baudrot, J. Snape, Charles R. Tyler^*

^*Corresponding author for this work

Environment and Geography

Research output: Contribution to journal › Article › peer-review

Abstract

Once released into the environment antibiotics can kill or inhibit the growth of bacteria, and in turn potentially have effects on bacterial community structure and ecosystem function. Environmental risk assessment (ERA) seeks to establish protection limits to minimise chemical impacts on the environment, but recent evidence suggests that the current regulatory approaches for ERA for antibiotics may not be adequate for protecting bacteria that have fundamental roles in ecosystem function. In this study we assess the differences in interspecies sensitivity of eight species of cyanobacteria to seven antibiotics (cefazolin, cefotaxime, ampicillin, sufamethazine, sulfadiazine, azithromycin and erythromycin) with three different modes of action. We found that variability in the sensitivity to these antibiotics between species was dependent on the mode of action and varied by up to 70 times for β-lactams. Probabilistic analysis using species sensitivity distributions suggest that the current predicted no effect concentration PNEC for the antibiotics may be either over or under protective of cyanobacteria dependent on the species on which it is based and the mode of action of the antibiotic; the PNECs derived for the macrolide antibiotics were over protective but PNECs for β-lactams were generally under protective. For some geographical locations we identify a significant risk to cyanobacteria populations based upon measured environmental concentrations of selected antibiotics. We conclude that protection limits, as determined according to current regulatory guidance, may not always be protective and might be better derived using SSDs and that including toxicity data for a wider range of (cyano-) bacteria would improve confidence for the ERA of antibiotics.

Original language	English
Article number	133804
Journal	Science of the Total Environment
Volume	695
DOIs	https://doi.org/10.1016/j.scitotenv.2019.133804
Publication status	Published - 10 Dec 2019

Bibliographical note

Publisher Copyright:
© 2019

Keywords

Antibiotics
Antimicrobial resistance
Environmental risk assessment
Pharmaceuticals
Predicted no effect concentration
Species sensitivity distribution

Access to Document

10.1016/j.scitotenv.2019.133804

Cite this

@article{573c51d286264f89b85b256f04d2da25,

title = "Variability in cyanobacteria sensitivity to antibiotics and implications for environmental risk assessment",

abstract = "Once released into the environment antibiotics can kill or inhibit the growth of bacteria, and in turn potentially have effects on bacterial community structure and ecosystem function. Environmental risk assessment (ERA) seeks to establish protection limits to minimise chemical impacts on the environment, but recent evidence suggests that the current regulatory approaches for ERA for antibiotics may not be adequate for protecting bacteria that have fundamental roles in ecosystem function. In this study we assess the differences in interspecies sensitivity of eight species of cyanobacteria to seven antibiotics (cefazolin, cefotaxime, ampicillin, sufamethazine, sulfadiazine, azithromycin and erythromycin) with three different modes of action. We found that variability in the sensitivity to these antibiotics between species was dependent on the mode of action and varied by up to 70 times for β-lactams. Probabilistic analysis using species sensitivity distributions suggest that the current predicted no effect concentration PNEC for the antibiotics may be either over or under protective of cyanobacteria dependent on the species on which it is based and the mode of action of the antibiotic; the PNECs derived for the macrolide antibiotics were over protective but PNECs for β-lactams were generally under protective. For some geographical locations we identify a significant risk to cyanobacteria populations based upon measured environmental concentrations of selected antibiotics. We conclude that protection limits, as determined according to current regulatory guidance, may not always be protective and might be better derived using SSDs and that including toxicity data for a wider range of (cyano-) bacteria would improve confidence for the ERA of antibiotics.",

keywords = "Antibiotics, Antimicrobial resistance, Environmental risk assessment, Pharmaceuticals, Predicted no effect concentration, Species sensitivity distribution",

author = "{Le Page}, Gareth and Lina Gunnarsson and Maciej Trznadel and Wedgwood, {Kyle C.A.} and Virgile Baudrot and J. Snape and Tyler, {Charles R.}",

note = "Publisher Copyright: {\textcopyright} 2019",

year = "2019",

month = dec,

day = "10",

doi = "10.1016/j.scitotenv.2019.133804",

language = "English",

volume = "695",

journal = "Science of the Total Environment",

issn = "0048-9697",

publisher = "Elsevier",

}

TY - JOUR

T1 - Variability in cyanobacteria sensitivity to antibiotics and implications for environmental risk assessment

AU - Le Page, Gareth

AU - Gunnarsson, Lina

AU - Trznadel, Maciej

AU - Wedgwood, Kyle C.A.

AU - Baudrot, Virgile

AU - Snape, J.

AU - Tyler, Charles R.

PY - 2019/12/10

Y1 - 2019/12/10

N2 - Once released into the environment antibiotics can kill or inhibit the growth of bacteria, and in turn potentially have effects on bacterial community structure and ecosystem function. Environmental risk assessment (ERA) seeks to establish protection limits to minimise chemical impacts on the environment, but recent evidence suggests that the current regulatory approaches for ERA for antibiotics may not be adequate for protecting bacteria that have fundamental roles in ecosystem function. In this study we assess the differences in interspecies sensitivity of eight species of cyanobacteria to seven antibiotics (cefazolin, cefotaxime, ampicillin, sufamethazine, sulfadiazine, azithromycin and erythromycin) with three different modes of action. We found that variability in the sensitivity to these antibiotics between species was dependent on the mode of action and varied by up to 70 times for β-lactams. Probabilistic analysis using species sensitivity distributions suggest that the current predicted no effect concentration PNEC for the antibiotics may be either over or under protective of cyanobacteria dependent on the species on which it is based and the mode of action of the antibiotic; the PNECs derived for the macrolide antibiotics were over protective but PNECs for β-lactams were generally under protective. For some geographical locations we identify a significant risk to cyanobacteria populations based upon measured environmental concentrations of selected antibiotics. We conclude that protection limits, as determined according to current regulatory guidance, may not always be protective and might be better derived using SSDs and that including toxicity data for a wider range of (cyano-) bacteria would improve confidence for the ERA of antibiotics.

AB - Once released into the environment antibiotics can kill or inhibit the growth of bacteria, and in turn potentially have effects on bacterial community structure and ecosystem function. Environmental risk assessment (ERA) seeks to establish protection limits to minimise chemical impacts on the environment, but recent evidence suggests that the current regulatory approaches for ERA for antibiotics may not be adequate for protecting bacteria that have fundamental roles in ecosystem function. In this study we assess the differences in interspecies sensitivity of eight species of cyanobacteria to seven antibiotics (cefazolin, cefotaxime, ampicillin, sufamethazine, sulfadiazine, azithromycin and erythromycin) with three different modes of action. We found that variability in the sensitivity to these antibiotics between species was dependent on the mode of action and varied by up to 70 times for β-lactams. Probabilistic analysis using species sensitivity distributions suggest that the current predicted no effect concentration PNEC for the antibiotics may be either over or under protective of cyanobacteria dependent on the species on which it is based and the mode of action of the antibiotic; the PNECs derived for the macrolide antibiotics were over protective but PNECs for β-lactams were generally under protective. For some geographical locations we identify a significant risk to cyanobacteria populations based upon measured environmental concentrations of selected antibiotics. We conclude that protection limits, as determined according to current regulatory guidance, may not always be protective and might be better derived using SSDs and that including toxicity data for a wider range of (cyano-) bacteria would improve confidence for the ERA of antibiotics.

KW - Antibiotics

KW - Antimicrobial resistance

KW - Environmental risk assessment

KW - Pharmaceuticals

KW - Predicted no effect concentration

KW - Species sensitivity distribution

UR - http://www.scopus.com/inward/record.url?scp=85070509610&partnerID=8YFLogxK

U2 - 10.1016/j.scitotenv.2019.133804

DO - 10.1016/j.scitotenv.2019.133804

M3 - Article

C2 - 31419690

AN - SCOPUS:85070509610

SN - 0048-9697

VL - 695

JO - Science of the Total Environment

JF - Science of the Total Environment

M1 - 133804

ER -

Variability in cyanobacteria sensitivity to antibiotics and implications for environmental risk assessment

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Cite this